← Open Payments lookup

KEROBIN LAPAWON: Open Payments

NPI 1255067369 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,741 in 144 payments from 18 companies in 2025. Trend: 2023 $820 · 2024 $1,900 · 2025 $2,741

Food & beverage: $2,630Education: $111
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.20$417
ABBVIE INC.23$405
Teva Pharmaceuticals USA, Inc.13$304
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$289
Alkermes, Inc.10$216
Axsome Therapeutics, Inc.11$185
Neurocrine BioSciences, Inc.15$175
Lundbeck LLC10$167
Vanda Pharmaceuticals Inc.9$158
Janssen Pharmaceuticals, Inc4$92

Products named: REXULTI, VRAYLAR, CAPLYTA, ARISTADA, Auvelity, INGREZZA, FANAPT, UZEDY.

Industry payments across FL — which companies pay providers there.